Introducing Our Novel Skin Rejuvenation Product, YuuthTM – Engineered to Eliminate the Cells that Cause “Inflammaging” in the Skin, Helping to Reverse the Signs of Aging.
Ponce Therapeutics is a longevity company using advanced technologies to develop novel therapeutics targeting the fundamental mechanisms of aging. Its lead programs, both senolytic and senomorphic in nature, utilize novel therapeutics discovered using our proprietary, state-of-the-art biotechnology platforms to restore the youthful balance of aged or “senescent” and young cells throughout the organs of the body. By targeting senescent cells, we have a unique opportunity to intervene in the aging process in ways that were once thought impossible.
Proprietary Platform
Targeting Senescent Cells for Secretory Modification or Elimination
Elimination of senescent cells or reduction of their pro-inflammatory secretory phenotype has been shown to suppress cancer and rejuvenate tissues.
Clinical Pipeline
Development of our lead programs targeting senescent cells in skin and throughout the body
PONCE’s lead programs, both senolytic and senomorphic, aim to restore a more youthful cellular balance throughout the body.